Description of the three fatalities in children and young people with COVID-19
| Patient | Age | Sex | Rheumatology diagnosis | Comorbidities | Glucocorticoids | Rheumatology treatment | Disease activity | Time from COVID-19 onset to death |
| 1 | <15 years | Female | Systemic lupus erythematosus | None | None | Antimalarials Intravenous Immunoglobulin | High | 8 days |
| 2 | <10 years | Female | Systemic lupus erythematosus | None | Yes (dose unknown) | None | High | 9 days |
| 3 | <5 years | Female | Auto-inflammatory syndrome | None | Yes (low dose) | Methotrexate | Unknown | 7 days |